The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Effect of Transplantation on the Medicare End-Stage Renal Disease Program
Abstract
The Medicare end-stage renal disease program has received considerable attention as a model of government funding for high-cost medical treatment. This paper examines how the program has been influenced by renal transplantation. In the past decade, the number of kidney transplantations has increased substantially, and the success rate of these procedures has improved. From 1980 to 1985, the number of transplantations increased by 10 percent per year. During that time, the survival rates for grafts from cadavers and living related donors increased by 7 and 3 percent, respectively, in part because of the introduction of cyclosporine. As a result, the fastest-growing group of beneficiaries of the Medicare end-stage renal disease program are those with functioning grafts. As of the end of 1985, these patients accounted for 18 percent of all beneficiaries and 32 percent of all beneficiaries less than 55 years of age. In the youngest groups, transplantation has reached a level sufficient to reduce the absolute numbers of patients on dialysis, beginning in 1983. Increases in transplantation are not evenly distributed among subgroups of beneficiaries. Relatively few patients 65 years of age and older receive transplants; blacks receive transplants at a rate roughly half that among whites, but the rate is increasing. Because the costs of maintaining patients with functioning grafts are only one third of those for patients on dialysis and because the quality of life is usually much better, renal transplantation is causing a convergence of the best clinical and economic outcomes for patients with end-stage renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
The Quality of Life of Patients with End-Stage Renal Disease
Evans, R. W., Manninen, D. L., Garrison, L. P., Hart, L. G., Blagg, C. R., Gutman, R. A., Hull, A. R., & Lowrie, E. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198502283120905 · Cited by 1,183
From the Health Care Financing Administration
Wilensky, G. R. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470200020007 · Cited by 635
A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation
The Canadian Multicentre Transplant Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141904 · Cited by 296
The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival.
Eggers, P. W., Connerton, R., & McMullan, M. R. (1984) · PubMed Central · Cited by 168
Self-citationHealth care technology and the inevitability of resource allocation and rationing decisions. Part I.
Evans, R. W. (1983) · PubMed · Cited by 168
Predicting Treatment Costs and Life Expectancy for End-Stage Renal Disease
Stange, P. V., & Sumner, A. T. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980705 · Cited by 132
Treatment of End-Stage Renal Disease
Relman, A. S., & Rennie, D. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010233031708 · Cited by 85
Health Care Technology and the Inevitability of Resource Allocation and Rationing Decisions
Evans, R. W. (1983) · JAMA · doi:10.1001/jama.1983.03330390051031 · Cited by 79
Erslev, A. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160207 · Cited by 72
Cited by
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
Carrero, J. J., Hecking, M., Chesnaye, N. C., & Jager, K. J. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.181 · Cited by 923
Shulman, N. B., Ford, C. E., Hall, W. D., Blaufox, M. D., Simon, D., Langford, H. G., & Schneider, K. A. (1989) · Hypertension · doi:10.1161/01.hyp.13.5_suppl.i80 · Cited by 676
Suthanthiran, M., & Strom, T. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310606 · Cited by 469
Kirk, A. D., Hale, D. A., Mannon, R. B., Kleiner, D. E., Hoffmann, S. C., Kampen, R. L., Cendales, L. K., Tadaki, D. K., Harlan, D. M., & Swanson, S. J. (2003) · Transplantation · doi:10.1097/01.tp.0000071362.99021.d9 · Cited by 436
Gall, M. A., Rossing, P., Sk�tt, P., Damsbo, P., Vaag, A., Bech, K., Dejgaard, A., Lauritzen, M., Lauritzen, E., Hougaard, P., et al. (1991) · Diabetologia · doi:10.1007/bf00400995 · Cited by 354
Metadata
- Authors
- Eggers, P. W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1988-01-28
- Volume
- 318
- Issue
- 4
- Pages
- 223-229
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2336195014
- Cited by
- 320
- References
- 11
- FWCI
- 48.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Transplantation on the Medicare End-Stage Renal Disease Program. https://app.cochat.ai/papers/10.1056/nejm198801283180406
- The paper
- Eggers, P. W. (1988). Effect of Transplantation on the Medicare End-Stage Renal Disease Program. New England Journal of Medicine. https://doi.org/10.1056/nejm198801283180406
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.